Am J Otolaryngol Head Neck Surg | Volume 4, Issue 2 | Research Article | Open Access

Cure Rates of Parathyroidectomy for Primary Hyperparathyroidism with Negative Localization Studies

Bassam Abboud1*, Christopher Abboud1, Alaa El-Kheir1, Fares Yared1 and Georges Assaf2

1Department of General Surgery, Lebanese University, Geitaoui Hospital, Lebanon
2Department of Anesthesiology, Lebanese University, Geitaoui Hospital, Lebanon

*Correspondance to: Bassam Abboud 

Fulltext PDF

Abstract

Purpose: This paper evaluates the outcomes of parathyroidectomy for primary hyperparathyroidism with negative localization studies.

Methods: All patients with primary hyperparathyroidism with negative preoperative ultrasound and MIBI scan who underwent parathyroidectomy were retrospectively included. Three groups were defined. Group 1 included the patients with negative ultrasound and MIBI. Group 2 included the patients with negative ultrasound and positive MIBI. Group 3 included the patients with positive ultrasound and negative MIBI.

Results: In Group 1%, 51% and 86% of patients had one adenoma and atypical localizations respectively. Unique adenoma and atypical localizations were showed in 87% and 93% of patients in Group 2 respectively. In Group 3%, 83% and 17% of patients had one adenoma and atypical localizations respectively. No cervical hematoma was noted. Transient recurrent laryngeal nerve palsy occurred in 2 patients. Seven patients required postoperative calcium supplementation for 2 months to 5 months, and one had recurrent hypercalcemia at follow-up. Cure rate was 98%, 3%.

Conclusion: When US and MIBI were negative, multiple lesions and atypical localizations were frequent. The success rate and postoperative complications were not affected with this event.

Keywords:

Primary hyperparathyroidism; MIBI scan; Ultrasound; Adenoma; Multiple lesions

Citation:

Abboud B, Abboud C, El-Kheir A, Yared F, Assaf G. Cure Rates of Parathyroidectomy for Primary Hyperparathyroidism with Negative Localization Studies. Am J Otolaryngol Head Neck Surg. 2021; 4(2): 1123..

Subscribe to Our Newsletter